MBX Biosciences (MBX) Interest Expenses (2023 - 2026)

MBX Biosciences (MBX) has 4 years of Interest Expenses data on file, last reported at $78.5 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 2386.1% year-over-year to $78.5 million; the trailing twelve-month figure through Mar 2026 stood at $78.5 million (up 2386.1% YoY), and the FY2025 full-year result was $97.8 million, up 135.79% from the prior year.
• Interest Expenses climbed to $78.5 million in Q1 2026, from $100000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $78.5 million in Q1 2026 to a low of $100000.0 in Q1 2024.
• A 4-year average of $15.3 million and a median of $3.2 million in 2025 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses slumped 97.8% in 2024 and soared 12834.0% in 2025, its largest moves.
• Tracing MBX's Interest Expenses over 4 years: stood at $4.5 million in 2023, then tumbled by 97.8% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then soared by 78411.0% to $78.5 million in 2026.
• Business Quant data shows MBX's Interest Expenses at $78.5 million in Q1 2026, $100000.0 in Q4 2025, and $38.2 million in Q3 2025.